UN
Unike
Community Contributor
AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Catalysts Are there any products or services that could move sales or earnings meaningfully? Most Immediate Catalyst (2024-2026): Tagrisso (Lung Cancer): Expanding into early-stage lung cancer Enhertu: Expanding beyond breast cancer into HER2-mutant lung & gastric cancers.
View narrativeSEK 2.55k
FV
37.6% undervalued intrinsic discount10.00%
Revenue growth p.a.
2users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
5 days ago author updated this narrative